Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,320 public trials 107 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

NCT00001095

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • Univ of Colorado Health Sciences Ctr Denver, Colorado, United States
  • Univ of Miami School of Medicine Miami, Florida, United States
  • Emory Univ Atlanta, Georgia, United States
View Trial Details
Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose

NCT00001056

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
View Trial Details
Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

NCT00000957

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • JHU AVEG Pittsburgh, Pennsylvania, United States
  • Vanderbilt Univ. Hosp. AVEG Nashville, Tennessee, United States
View Trial Details
Completed

A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women

NCT00000758

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +23 more
Locations
  • Usc La Nichd Crs Los Angeles, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Northwestern University CRS Chicago, Illinois, United States
  • Cook County Hosp. CORE Ctr. Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

Optimizing Treatment for Treatment-Experienced, HIV-Infected People

NCT00537394

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States
  • University of Southern California CRS Los Angeles, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
View all 64 locations
View Trial Details
Completed

A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers

NCT00000832

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB AVEG Birmingham, Alabama, United States
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • JHU AVEG Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Study of Stem Cells and Filgrastim

NCT00001071

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
View Trial Details

Related conditions